asa statement on glp 1 Perioperative management of patients taking glucagon-like peptide-1 receptor agonists: a restrictive fasting regimen is not necessary. Comment Br J Anaesth 2025; 135: 48–78 GLP-1 RA guidance roundup -
Description
The inhibition of the onset and progression of DKD is an urgent issue, and the development of therapeutic approaches against DKD is required
TNBS ileitis evokes hyperexcitability and changes in ionic membrane properties of nociceptive DRG neurons
Bariatric Surgery versus Intensive Medical Therapy for Diabetes 5-Year Outcomes
Semaglutide, marketed as Ozempic, Wegovy, and Rybelsus, is an FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management
